Anixa Biosciences is trading 5.20% up at $3.34; the move may reflect broader positive sentiment, though no new company-specific announcement was identified to explain it. - Major U.S. indices were higher by more than 0.5%, but this association is not a confirmed cause. - Shares are up from the November 6 close of $3.17. - The latest company release found was November 4, about a planned ovarian cancer CAR-T trial presentation.